Sonia Luque

7PUBLICATIONS
10CO-AUTHORS
Medical bacteriologyMedical infection agents (incl. prions)PharmacogenomicsEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 06, 2026
Early adequate linezolid concentrations and clinical outcomes in confirmed Gram-positive infections: the role of therapeutic drug monitoring.

|Dec 16, 2025
Preventing resistance development in infections by OXA β-lactamase-producing Pseudomonas aeruginosa: correlating clinical outcomes with hollow-fibre model input.

María M Montero, Almudena Fernández-Muñoz, Sandra Domene-Ochoa

|Nov 09, 2023
Colistin plasma concentrations are not associated with better clinical outcomes in patients with pneumonia caused by extremely drug-resistant Pseudomonas aeruginosa.

Luisa Sorlí, Sonia Luque, Jian Li

|Jun 13, 2022
Comparison of Ceftolozane/Tazobactam Infusion Regimens in a Hollow-Fiber Infection Model against Extensively Drug-Resistant Pseudomonas aeruginosa Isolates.

María Milagro Montero, Sandra Domene-Ochoa, Carla López-Causapé

|Jun 03, 2022
Therapeutic Drug Monitoring and Prolonged Infusions of Ceftolozane/Tazobactam for MDR/XDR Pseudomonas aeruginosa Infections: An Observational Study.

María Eugenia Navarrete-Rouco, Sònia Luque, Luisa Sorlí

|Jul 28, 2021
Time-Kill Evaluation of Antibiotic Combinations Containing Ceftazidime-Avibactam against Extensively Drug-Resistant Pseudomonas aeruginosa and Their Potential Role against Ceftazidime-Avibactam-Resistant Isolates.

María M Montero, Sandra Domene Ochoa, Carla López-Causapé

Pageof 2

Frequent Collaborators

3 joint publications

Juan P Horcajada

3 joint publications

María Milagro Montero

2 joint publications

Luisa Sorlí

1 joint publications

W Hope